Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2005 1
2007 3
2008 2
2016 1
2020 4
2021 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Real-World Efficacy and Safety of Extended-Release Methylphenidate (PRC-063) in the Treatment of ADHD in Pediatric and Adult Subjects: Results of a Phase IV Multicenter Comparison With Lisdexamfetamine Dimesylate.
van Stralen J, Parhar G, Parhar A, Tourjman V, Khattak S, Ahmed T, Donnelly GAE, Ratz J. van Stralen J, et al. Among authors: donnelly gae. J Atten Disord. 2023 May;27(7):743-756. doi: 10.1177/10870547231172767. Epub 2023 May 5. J Atten Disord. 2023. PMID: 37144295
Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension.
Weiss MD, Cutler AJ, Kollins SH, Donnelly GAE. Weiss MD, et al. Among authors: donnelly gae. J Child Adolesc Psychopharmacol. 2021 Nov;31(9):610-622. doi: 10.1089/cap.2021.0034. Epub 2021 Oct 8. J Child Adolesc Psychopharmacol. 2021. PMID: 34637343 Clinical Trial.
Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study.
Childress AC, Brams MN, Cutler AJ, Donnelly GAE, Bhaskar S. Childress AC, et al. Among authors: donnelly gae. J Child Adolesc Psychopharmacol. 2020 Dec;30(10):580-589. doi: 10.1089/cap.2020.0109. Epub 2020 Oct 22. J Child Adolesc Psychopharmacol. 2020. PMID: 33090921 Free PMC article. Clinical Trial.
Once-daily multilayer-release methylphenidate in a double-blind, crossover comparison to immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.
Weiss M, Hechtman L, Turgay A, Jain U, Quinn D, Ahmed TS, Yates T, Reiz JL, Donnelly GA, Harsanyi Z, Darke AC. Weiss M, et al. Among authors: donnelly ga. J Child Adolesc Psychopharmacol. 2007 Oct;17(5):675-88. doi: 10.1089/cap.2006.0101. J Child Adolesc Psychopharmacol. 2007. PMID: 17979587 Clinical Trial.
14 results